NeuroOne Medical Technologies GAAP EPS of -$0.25 misses by $0.02, revenue of $2.4M misses by $0.18M
2026-05-12 11:42:27 ET
More on NeuroOne Medical Technologies
- NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
- NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript
- NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
- NeuroOne outlines ISO 13485 certification in latter part of 2026 while targeting drug delivery availability in second half of fiscal 2026
- NeuroOne targets at least $10.5M revenue in 2026 while advancing brain and pain therapy platforms
Read the full article on Seeking Alpha
For further details see:
NeuroOne Medical Technologies GAAP EPS of -$0.25 misses by $0.02, revenue of $2.4M misses by $0.18MNASDAQ: NMTC
NMTC Trading
0.57% G/L:
$3.53 Last:
5,948 Volume:
$3.44 Open:



